713 Nanrilkefusp alfa, a high-affinity IL-15Rβγ agonist, promotes an innate and adaptive anti-tumour inflammatory environment as single agent or combined with anti-PD-1 in patients with advanced cancers - Ulrich Moebius; Radek Špíšek; David Béchard; Nada Podzimkova; Irena Adkins; Richard Sachse; Joachim Kiemle-Kallee; Ekaterina Simonova; Lenka Palova Jelinkova; Petr Danek; Martin Steegmaier (Journal for ImmunoTherapy of Cancer, 2023)